Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
iRhythm Technologies Inc

Start price
Target price
Perf. (%)
€137.00
29.03.22
-
29.03.23
-16.79%
29.03.23

Saftman 
29.03.22 50%
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.05
03.01.23
-
03.01.24
-73.34%
28.03.23

Could be worthwhile Investment >10% per year
melinda 
03.01.23 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€64.50
22.03.22
-
22.03.23
-43.57%
23.03.23

Saftman 
22.03.22 50%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€7.65
21.03.22
€11.00
21.03.23
-7.01%
22.03.23

Could be worthwhile Investment >10% per year
Higher risks for its business
tbackenh 
21.03.22 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.04
08.03.23
€34.00
08.03.24
-22.54%
21.03.23

Could be very worthwhile Investment >20% year
DomRuinart 
08.03.23 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€7.14
05.03.23
-
05.03.24
-22.15%
18.03.23

Probably not worthwhile Investment
Very low/no dividend yield expected
fenjal 
05.03.23 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.43
06.03.23
-
06.03.24
-23.34%
17.03.23

Risky Investment
Wolf_of_WS 
06.03.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.44
06.03.23
-
06.03.24
-57.46%
17.03.23

Could be worthwhile Investment >10% per year
thomasw 
06.03.23 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.29
06.03.23
-
06.03.24
-13.18%
17.03.23

Risky Investment
thomasw 
06.03.23 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€6.62
01.03.23
-
01.03.24
-15.51%
17.03.23

Could be very worthwhile Investment >20% year
quelbe60 
01.03.23 50%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€21.29
16.03.22
€56.00
16.03.23
149.27%
17.03.23

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
16.03.22 60%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€2.51
07.03.22
-
07.03.23
21.39%
08.03.23

Probably not worthwhile Investment
Lokrim 
07.03.22 20%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.76
11.12.22
-
11.12.23
-6.82%
06.03.23

Could be worthwhile Investment >10% per year
bundfuture 
11.12.22 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€14.57
01.03.22
-
01.03.23
-43.77%
02.03.23

Saftman 
01.03.22 50%
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€11.54
21.02.22
€15.00
21.02.23
2.90%
22.02.23

Could be worthwhile Investment >10% per year
melinda 
21.02.22 50%
sell
MyMD Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.04
07.02.23
€1.00
07.02.24
-7.35%
18.02.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
kostojunior 
07.02.23 40%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.44
22.01.23
-
22.01.24
-30.29%
16.02.23

Wolf_of_WS 
22.01.23 50%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€1.74
03.10.22
€2.35
03.10.23
-15.49%
13.02.23

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
03.10.22 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.24
10.02.22
€3.80
10.02.23
-4.81%
11.02.23

Could be worthwhile Investment >10% per year
melinda 
10.02.22 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.44
23.01.23
€33.00
23.01.24
-0.24%
06.02.23

Could be very worthwhile Investment >20% year
DomRuinart 
23.01.23 50%
buy
Sientra Inc.

Start price
Target price
Perf. (%)
€1.84
02.02.23
€3.60
02.02.24
-4.62%
06.02.23

Could be very worthwhile Investment >20% year
DomRuinart 
02.02.23 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.03
05.02.22
€20.00
05.02.23
-57.41%
06.02.23

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
jobah 
05.02.22 30%
sell
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.75
26.12.22
-
26.12.23
48.74%
05.02.23

Risky Investment
daimler1 
26.12.22 50%
sell
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€1.11
01.02.23
-
01.02.24
-0.36%
05.02.23

Risky Investment
Wolf_of_WS 
01.02.23 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€87.29
01.02.22
-
01.02.23
-88.23%
02.02.23

Could be worthwhile Investment >10% per year
Fair valuation
Revenue growth >5% per year expected
Standard Investments for future growth
Amped 
01.02.22 0%